Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

HDFC Business Cycle Fund · Regular ✕HDFC Pharma and Healthcare Fund · Regular ✕

Growth of ₹10,000

Basics

HDFC Business Cycle FundHDFC Pharma and Healthcare Fund
CategorySectoral / ThematicSectoral / Thematic
PlanRegularRegular
Fund houseHDFCHDFC
NAV₹15.6450₹22.8170
NAV date20 Nov 202620 Nov 2026
History—3.1 years
Expense ratio2.1%2.1%
StarsNot rated★★★★★
Growth Score—93.90

Returns

HDFC Business Cycle FundHDFC Pharma and Healthcare Fund
1 month—+12.87%
3 months—+6.85%
6 months—+17.20%
YTD—+32.43%
1 year—+30.73%
3 years (CAGR)—+29.16%
5 years (CAGR)——
10 years (CAGR)——
Since launch—+30.28%

Risk

HDFC Business Cycle FundHDFC Pharma and Healthcare Fund
Volatility—15.8%
Downside volatility—8.6%
Sharpe—1.44
Sortino—2.64
Calmar—1.94
Return / risk—1.85
Deepest fall—−15.07%
Days to recover—133
Below its high—+0.00%

Against benchmark

HDFC Business Cycle FundHDFC Pharma and Healthcare Fund
Alpha—+6.36%
Beta—0.97
R²—85.0%
Up capture—106.7%
Down capture—74.4%
Tracking error—6.1%
Information ratio—0.97
Treynor—0.22

Consistency

HDFC Business Cycle FundHDFC Pharma and Healthcare Fund
Best 1-year—+64.96%
Middle 1-year—+21.84%
Worst 1-year—+0.52%
1-year periods with a loss—0.0%
Middle 3-year—+28.68%
Positive months—69.4%
Best day—+3.19%
Worst day—−3.62%
Worst 5% day—−1.50%
Positive days—58.1%
NAVs a year—247

SIP of ₹10,000 a month

HDFC Business Cycle FundHDFC Pharma and Healthcare Fund
5-year XIRR——
5-year value——
3-year XIRR—+26.26%
1-year XIRR—+39.84%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth